I. Adenosine and Cardioprotection -- 1. Adenosine and Cardioprotection -- II. Cardioprotection and Mechanisms of Ischemic and Reperpusion Injury -- 2. Concept of Cardioprotection Against Myocardial Ischemia -- 3. The Late Phase of Preconditioning Against Myocardial Stunning -- 4. Coronary Perfusion as the Major Determinant of Myocardial Contractility in the Heart: Implication for Myocardial Hibernation -- 5. Myocardial Protection From Reperfusion Injury With Adenosine -- III. Cellular Mechanisms of Cardioprotection in Ischemic Preconditioning -- 6. Protein Kinase C - the Key-Enzyme in Ischรฉmic Preconditioning? -- 7. Adenosine, Cardioprotection and Potential Mechanisms -- 8. Activation of Ecto-5'-nucleotidase Mediates Cardioprotection in Ischemic Preconditioning: Important Role of Protein Kinase C -- 9. Role of Mn-SOD Induction in the Second Window Phenomenon of Preconditioning of Ischemic Hearts -- 10. Opioid Receptors, KATP Channels and Ischemic Preconditioning -- 11. Bradykinin and Preconditioning Against Infarction -- 12. Preconditioning in Human Muscle and Myocytes -- 13. Protein Kinase C and Adenosine Synergistically Activate ATP-Sensitive Potassium Currents: Implications for Ischemic Preconditioning -- Clinical Application of New Strategies to Protect The Ischemic Heart -- 14. Adenosine and Myocardial Protection in Humans -- 15. Clinical Applications of Ischemic Preconditioning -- 16. Clinical Pharmacology of Preconditioning and Adenosinergic Drugs -- 17. Clinical Application of Ischemic Preconditioning by ATP-Sensitive Potassium Channel Openers -- 18. Potassium Channel Openers and Cardiac Surgery -- 19. Anti-ischemic Effects of the ATP-sensitive Potassium Channel Opener During Coronary Angioplasty -- 20. Clinical Impact of Ischemic Preconditioning on Infarct Size and Coronary No-reflow Phenomenon after Successful Recanalization in the Acute Myocardial Infarction